Skip to content

A Study on Accuracy Improvement of Repeated Measure Uroflowmetry- Electromyography

A Study on Accuracy Improvement of Repeated Measure Uroflowmetry- Electromyography

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03399877
Enrollment
51
Registered
2018-01-17
Start date
2017-12-04
Completion date
2019-10-31
Last updated
2019-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Enuresis

Brief summary

Uroflowmetry(UF) has been the standard first-line diagnostic tool for the evaluation of pediatric voiding dysfunction. But recently, UF combined with pelvic flow electromyography(EMG) is emphasized and recommended to analyze the separate contributions of the detrusor and bladder outlet and sole UF is discouraged except for the follow-up study after abnormal UF/EMG result(Bauer et al., 2015). However, electrode itself can disturb pelvic floor relaxation and there is no evidence about necessity of consecutive UF/EMG test. Therefore, the investigators are going to compare three different methods (Primary-Secondary: UF/EMG-UF/EMG, UF/EMG-sole UF, sole UF-UF/EMG)

Interventions

BIOLOGICALCombining electromyography with uroflowmetry (group A)

Children who assigned group A perform uroflowmetry-electromyography for the first and subsequently perform uroflowmetry-electromyography again.

BIOLOGICALUroflowmetry(Group B)

Children who assigned Group B perform uroflowmetry-electromyography for the first, and subsequently perform sole uroflowmetry.

BIOLOGICALUroflowmetry-Combining electromyography with uroflowmetry (Group C)

Children who assigned Group C firstly perform sole uroflowmetry and subsequently perform uroflowmetry-electromyography.

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

Children who meet the inclusion criteria and no exclusion criteria are assigned to perform one of the three test protocols in order of registration according to a computer gererated randomization list. Children who assigned group A perform uroflowmetry-electromyography for the first and subsequently perform uroflowmetry-electromyography again. Children who assigned Group B perform uroflowmetry-electromyography for the first, and subsequently perform sole uroflowmetry. Children who assigned Group C firstly perform sole uroflowmetry and subsequently perform uroflowmetry-electromyography.

Eligibility

Sex/Gender
ALL
Age
5 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

1\) children aged 5 to 11.9 who visit pediatric urology department for enuresis.

Exclusion criteria

1. If children have experience of performing uroflowmetry or uroflowmetry-electromyography. 2. If children do not cooperate on performing the test 3. If enuresis is caused by neurological or anatomical problem.

Design outcomes

Primary

MeasureTime frameDescription
maximum flow rate(Qmax=cc/s)One dayThe maximum flow rate is the most important uroflowmetry index to diagnose bladder outlet obstruction or bladder contractility.

Secondary

MeasureTime frameDescription
Uroflow curve patternOne dayUroflow curve pattern: There are 5 uroflow curve patterns, bell-shaped, tower-shaped, interrupted-shaped, staccato-shaped and plateau shaped by uroflowmetry. The shape is determined by detrusor contractility and influenced by abdominal straining, coordination with the bladder outlet musculature and any distal anatomic obstruction.
post void residualOne daypost-void residual(cc): ultrasonographic bladder scan machines calculates bladder volume. PVR measurements in neurologically intact children are highly variable. PVR must be obtained immediately after voiding(\<5min)
synergy or dyssynergy between the bladder and the pelvic floor.One daysynergy or dyssynergy between the bladder and the pelvic floor is abstained by combining electromyography with uroflowmetry.

Countries

South Korea

Contacts

Primary ContactYong Seung Lee, MD
asforthelord@yuhs.ac82-2-2228-2310

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026